Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine-Reference-Cited by-同舟云学术

Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine

Published:2003-06-20 Issue:1 Volume:122 Page:53-60
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Galmarini Carlos María,Thomas Xavier,Graham Kathryn,El Jafaari Assia,Cros Emeline,Jordheim Lars,Mackey John R.,Dumontet Charles

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04386.x/fullpdf

Reference35 articles.

1. Human erythrocyte pyrimidine 5′-nucleotidase, PN-I;Amici;Archives of Biochemistry and Biophysics,2002

2. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15;Beckwith;Journal of the National Cancer Institute,1993

3. Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes;Coleman;Blood,1975

4. Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukaemia;Colly;Seminars in Oncology,1987

5. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562;Dumontet;British Journal of Haematology,1999

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment;International Journal of Molecular Sciences;2024-09-11

2. Structural characterization and origin of surface vesicles in monocytes: another membranous pathway from cytoplasm to cell surface;Ultrastructural Pathology;2023-11-30

3. Clinical use of biomarkers in the field of cytotoxic nucleoside analogues;Nucleosides, Nucleotides & Nucleic Acids;2023-10-24

4. 5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics;European Journal of Haematology;2022-09-16

5. The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias;Haematologica;2022-02-17